INSIGHTS ON REGULATORY COMPLIANCE

• Reducing Risk, Decreasing Timelines, And Optimizing Outcomes

  Explore the challenges of cell line development (CLD) in biologics commercialization and discover how integrated solutions can streamline your strategy, reduce risks, and optimize outcomes.

• OEE And Product Inspection

  Explore the calculation of Overall Equipment Effectiveness (OEE) and the impact of product inspection equipment on OEE in the pharmaceutical industry.

• Vision Inspection Software: The Missing Link In Digital Transformation

  AI and MES can’t meet pharma’s visual inspection demands. Discover how purpose-built software ensures defect detection, compliance, and paperless quality for safer, more efficient operations.

• Sample Sizes For Performance Testing Of Combination Products, Packaging

  When developing combination products or evaluating primary packaging for drug products one must evaluate the performance of the devices and the packaging to ensure that they are fit-for-purpose.

• Improving Bioprocess Monitoring And Control With Multivariate Data Analysis

  12/9/2024

  Learn about multivariate data analysis (MVDA) techniques, like PCA and PLS, that enable near real-time monitoring, prediction, and optimization of biomanufacturing processes.

• Navigating Global Regulatory Landscapes In An Evolving Biopharma Industry

  4/15/2025

  Minimize regulatory risks and ensure compliance in the evolving biopharma sector. Watch this on-demand discussion for insights on change management, supplier collaboration, and future market trends.

• Biotech Firm Streamlines Maintenance, Calibration & Validation With RAM

  8/8/2025

  Explore how a U.S. biotech company uses RAM to centralize maintenance, calibration, and validation to improve compliance, efficiency, and visibility across multiple facilities.

• Improved GLP-1 Receptor Agonist Peptide Recovery

  6/30/2025

  Discover how an innovative technology enhances LC-MS analysis of GLP-1 receptor agonists by minimizing peptide loss and improving assay sensitivity and consistency.

• The Hidden Threat To Product Purity: Neglected Seals In Synthesis Columns

  6/3/2025

  In biopharmaceutical manufacturing, seemingly minor components like seals can pose significant risks to product purity. Overlooking them can lead to contamination and costly delays.